Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.3841
+0.0241 (6.69%)
At close: Sep 15, 2025, 4:00 PM EDT
0.3896
+0.0055 (1.43%)
After-hours: Sep 15, 2025, 7:48 PM EDT
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $15.15 million as of September 15, 2025. Its market cap has decreased by -88.06% in one year.
Market Cap
15.15M
Enterprise Value
-13.89M
1-Year Change
-88.06%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $15.15M, a decrease of -96.91%. That is a compound annual growth rate of -50.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 14.20M | -37.42% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.14% |
| Sep 18, 2020 | 489.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |